Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alopecia
NIOXIN(R) Delivers the Future to Scalp and Hair Care, Introduces the First Genetic Test to Determine the Likelihood of Hair Loss
March 21st, 2008
NIOXIN(R) Research Laboratories Inc., the leader in professional skincare for the scalp, announced that it will offer an easy to access and understand genetic test that determines the likelihood of developing male pattern baldness -- before it actually begins to happen. Similarly, a test for women is being developed and may be available soon. NIOXIN(R) has entered into an agreement with HairDX, a biotech start-up based in Irvine, CA, to offer the test as part of its next generation effort in introducing scientifically proven scalp and hair products. HairDX is the first genome test to be made available to consumers in helping assess their risk and genetic predisposition...
Source: Health Business Week (2008-03-21)
|
